Liver involvement in multiple myeloma

Area of Science:

• Hematology
• Hepatology
• Oncology

Background:

• Multiple myeloma is a hematologic malignancy characterized by malignant plasma cell proliferation.
• Liver involvement is a potential complication of multiple myeloma, but its incidence and clinical manifestations require further elucidation.

Purpose of the Study:

• To investigate the incidence and clinical manifestations of liver involvement in patients with multiple myeloma.
• To determine the prognostic significance of liver infiltration by plasma cells in multiple myeloma.

Main Methods:

• Retrospective review of 128 patient records with multiple myeloma.
• Histologic examination of liver tissue in a subset of patients (n=21).

Main Results:

• Liver involvement was observed in various forms, including plasma cell infiltration (n=10), myeloid metaplasia (n=4), amyloidosis (n=2), and toxic hepatitis (n=2).
• Clinical signs of plasma cell infiltration included hepatomegaly (n=7), elevated liver enzymes (n=5), and portal hypertension (n=2).
• Jaundice was primarily associated with hepatitis or extrahepatic cholestasis.

Conclusions:

• Liver infiltration by plasma cells is a recognized manifestation of multiple myeloma.
• Clinical presentation of liver involvement is diverse and may include hepatomegaly and abnormal liver enzymes.
• Liver infiltration by plasma cells does not appear to significantly affect the overall prognosis of multiple myeloma.